Literature DB >> 24464837

Tissue kallikrein protects rat hippocampal CA1 neurons against cerebral ischemia/reperfusion-induced injury through the B2R-Raf-MEK1/2-ERK1/2 pathway.

Zheng Wang1, Xiang Han, Mei Cui, Kun Fang, Zhengyu Lu, Qiang Dong.   

Abstract

We have documented that tissue kallikrein (TK) prevents neurons from hypoxia/reoxygenation injury through the B2R-ERK1/2 pathway and the antihypoxic function of TK through Homer1b/c-ERK1/2 signaling pathways. The present study investigates the molecular mechanisms of exogenous TK activation of the B2R-ERK1/2 pathway through the β-arrestin-2 assembled B2R-Raf-MEK1/2 signaling module in vivo. The cresyl violet staining results indicated that exogenous TK protected the rat hippocampal CA1 neurons against cerebral ischemia/reperfusion (I/R) injury. The immunoprecipitation (IP) and immunoblotting (IB) results revealed that exogenous TK upregulated the β-arrestin-2 assembled B2R-Raf-MEK1/2 signaling module and upregulated the phosphorylation of Raf (p-Raf), MEK1/2 (p-MEK1/2), and ERK1/2 (p-ERK1/2). Meanwhile, exogenous TK upregulated the expression of nuclear factor-κB (NF-κB), depressed the release of cytochrome c (Cyt c) and bax from mitochondria to the cytosol, and depressed the activation of caspase-3. Take together, our results suggest that exogenous TK attenuated the cerebral I/R induced rat hippocampal CA1 neurons injury through activating the β-arrestin-2 assembled B2R-Raf-MEK1/2 signaling module and that the activated B2R-Raf-MEK1/2 signaling module could upregulate the expression of NF-κB, decrease the release of cytochrome c and bax from mitochondria to the cytosol, and depress the activation of caspase-3.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ERK1/2; bradykinin 2 receptor; cerebral ischemia; hippocampal CA1 neuron; tissue kallikrein

Mesh:

Substances:

Year:  2014        PMID: 24464837     DOI: 10.1002/jnr.23325

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Effect of semi-rapid maxillary expansion in children with obstructive sleep apnea syndrome: 5-month follow-up study.

Authors:  Saimir Hoxha; Ecem Kaya-Sezginer; Filiz Bakar-Ates; Oğuz Köktürk; Ufuk Toygar-Memikoğlu
Journal:  Sleep Breath       Date:  2018-02-17       Impact factor: 2.816

2.  Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis.

Authors:  Naveed Sabir; Tariq Hussain; Yi Liao; Jie Wang; Yinjuan Song; Muhammad Shahid; Guangyu Cheng; Mazhar Hussain Mangi; Jiao Yao; Lifeng Yang; Deming Zhao; Xiangmei Zhou
Journal:  Cells       Date:  2019-05-05       Impact factor: 6.600

3.  High Level of Serum Tissue Kallikrein Is Associated with Favorable Outcome in Acute Ischemic Stroke Patients.

Authors:  Fei Wu; Yifeng Ling; Lumeng Yang; Xin Cheng; Qiang Dong; Wenjie Cao
Journal:  Dis Markers       Date:  2019-06-02       Impact factor: 3.434

Review 4.  Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.

Authors:  Robert Gábriel; Etelka Pöstyéni; Viktória Dénes
Journal:  Front Neurosci       Date:  2019-10-09       Impact factor: 4.677

5.  Tissue Kallikrein Activity, Detected by a Novel Method, May Be a Predictor of Recurrent Stroke: A Case-Control Study.

Authors:  Xiao Ran; Qin Zhang; Dao Wen Wang
Journal:  Dis Markers       Date:  2015-09-14       Impact factor: 3.434

6.  Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats.

Authors:  Ruifeng Shi; Kunxiong Yuan; Bin Hu; Hongfei Sang; Lizhi Zhou; Yi Xie; Lili Xu; Qinqin Cao; Xin Chen; Lingling Zhao; Yunyun Xiong; Gelin Xu; Xinfeng Liu; Ling Liu; Renliang Zhang
Journal:  Oxid Med Cell Longev       Date:  2016-06-30       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.